Biotech entity
Every one of those 1 sits in a single category, pharma. SAB Biotherapeutics is most often covered alongside DiversitAb, which appears in 1 of these 1 story. At 5, the average consequence score sits below the same-window beat average of 6.3.
Last mentioned: Mar 17, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. SAB Biotherapeutics is most often covered alongside DiversitAb, which appears in 1 of these 1 story. At 5, the average consequence score sits below the same-window beat average of 6.3. Each story carries 2 original sources on average, compared with 3.3 for the broader beat in this window. SAB Biotherapeutics appears in 1 tracked Biotech story from March 17, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering SAB Biotherapeutics. Shared-story counts are live from our verified record — not editorial picks.
Wall Street Zen Downgrade
SABS and SSSS both receive Sell ratings from Wall Street Zen.
SAB-142 Clinical Progress
SAB Biotherapeutics continues enrollment for its Phase 1/2 trial in Type 1 Diabetes.
Strategic Pivot
Company shifts focus from infectious diseases to immunology and chronic conditions.
Wall Street Zen has downgraded SAB Biotherapeutics (SABS) and its investor SURO Capital (SSSS) to Sell ratings. The move signals increasing caution regarding SAB's clinical-stage polyclonal antibody platform and the broader venture-backed biotech ecosystem.
Source: tickerreport.com · tickerreport.com
SAB Biotherapeutics is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
